| 注册
首页|期刊导航|基础医学与临床|肥胖模型小鼠肝脏的病理变化及代谢组分析

肥胖模型小鼠肝脏的病理变化及代谢组分析

丁宝锋 王小爽 王芳 余佳

基础医学与临床2024,Vol.44Issue(5):699-704,6.
基础医学与临床2024,Vol.44Issue(5):699-704,6.DOI:10.16352/j.issn.1001-6325.2024.05.0699

肥胖模型小鼠肝脏的病理变化及代谢组分析

Pathological changes and metabolome analysis of liver in obese mouse models

丁宝锋 1王小爽 1王芳 1余佳1

作者信息

  • 1. 中国医学科学院基础医学研究所北京协和医学院基础学院重大疾病共性机制研究全国重点实验室,北京 100005
  • 折叠

摘要

Abstract

Objective To detect the pathological changes in obese mice liver and explore the effects of obesity on hepatic metabolism.Methods Obese mouse model was successfully constructed by consecutive 24 weeks of high fat diet(HFD),while control group was fed with a standard chow diet(CD).After 24 weeks,mice liver was dissec-ted,and the pathological characteristics of liver were observed with hematoxylin-eosin(HE)staining and Sirius red staining.The metabolome of liver was detected by ultra-high performance liquid chromatography-mass spectrometry(UPLC-MS)after extraction by 80%methanol.Principal component analysis(PCA),differential metabolite analy-sis and KEGG pathway enrichment analysis were performed to find the metabolic changes in the liver of obese mice.Results After 24 weeks of high fat diet,the body weight and liver weight of HFD group mice were much higher than that of CD group mice.Besides,HFD group mice liver showed severe steatosis and slight fibrosis.There were also significant differences in liver metabolites between HFD and CD groups,and the metabolic changes were mainly enriched in pathways of phenylalanine metabolism,citric acid cycle(TCA cycle),sphingolipid metabolism,arginine biosynthesis and primary bile acid biosynthesis.Conclusions The obese mouse model was successfully constructed,and the pathological characteristics of obese mice liver were elucidated.At the same time,the main metabolic path-way changes of obese mice liver were further revealed by metabonomics analysis.

关键词

肥胖/肝脏/代谢组/饮食诱导

Key words

obesity/liver/metabolome/diet induction

分类

医药卫生

引用本文复制引用

丁宝锋,王小爽,王芳,余佳..肥胖模型小鼠肝脏的病理变化及代谢组分析[J].基础医学与临床,2024,44(5):699-704,6.

基金项目

国家重点研发计划(2019YFA0801800) (2019YFA0801800)

基础医学与临床

OACSTPCD

1001-6325

访问量7
|
下载量0
段落导航相关论文